Bank of America
IMUX icon

Bank of America’s Immunic IMUX Stock Holding History

Bank of America’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-150
Closed -$243K – 7368
2015
Q3 		$243K Buy
+150
New +$750K ﹤0.01% 5227

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bank of America's IMUX Position: Q1 2026 in Review

Bank of America increased its Immunic (IMUX) stake by 79,828% in Q1 2026, buying an estimated $129K and bringing the position to 14,387 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #5430.

Bank of America first reported a position in IMUX in Q2 2014 and has held it in 47 quarters since. The position peaked at $825K in Q4 2014. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Bank of America held 14,387 shares of Immunic worth $160K as of Q1 2026.
  • Bank of America bought 14,369 Immunic shares in Q1 2026, an estimated $129K.
  • Immunic made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5430 holding.
  • Bank of America first reported a position in Immunic in Q2 2014 and has held it in 47 quarters since.
  • Bank of America's Immunic position peaked at $825K in Q4 2014.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.